全国服务咨询热线:

18438616290

Products产品中心
首页 > 产品中心 > 生化试剂 > 小分子化合物 > abs816460Flubendazole 31430-15-6

Flubendazole 31430-15-6

简要描述:Flubendazole 31430-15-6
Flubendazole is an anthelmintic that is used to treat worm infection in humans. It is available OTC in Europe.

  • 产品型号:abs816460
  • 厂商性质:生产厂家
  • 更新时间:2026-02-14
  • 访  问  量:1932

详细介绍

品牌absinCAS31430-15-6
分子式C16H12FN3O3纯度99%
分子量313.29货号abs816460
规格10mg供货周期现货
主要用途used to treat worm infection in humans应用领域化工,生物产业,农林牧渔,制药/生物制药,综合

Flubendazole  31430-15-6

产品描述
描述

Flubendazole is an anthelmintic that is used to treat worm infection in humans. It is available OTC in Europe.

纯度
99%
储存/保存方法
Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution.
基本信息
别名
氟苯咪唑
外观
白色固体
可溶性/溶解性
DMSO : 3 mg/mL (9.58 mM)
生物活性
靶点
Atg4B
In vitro(体外研究)
Flubendazole results in morphological changes included contraction of the soma region, formation of blebs on the tegument, rostellar disorganization, loss of hooks and destruction of microtriches in Echinococcus granulosus. Flubendazole have a bicyclic ring system in which a benzene has been fused to the -4 and -5 positions of the heterocycle (imidazole). Flubendazole and Albendazole shows similar potency in affecting rat embryonic development in vitro, inducing retardation of growth and dysmorphogenic effects at concentrations ≥0.5 μg/mL.
In vivo(体内研究)
Flubendazole (6.32 mg/kg/day) initially induces an arrest of embryonic development followed by a generalized cell death that leads to 100% embryolethality by gestation day (GD) 12.5. Flubendazole (3.46 mg/kg/day) markedly reduces embryonic development by GD 12.5 without causing cell death. Flubendazole in olive oil causes a statistically significant increase in embryolethality at doses of 7.83 mg/kg per day and higher, with complete resorption in all dams at 31.33 mg/kg per day in rats. Flubendazole treatment causes a slight increase of metyrapone and daunorubicin activities in hepatic as well as intestinal cytosol in birds. Flubendazole treatment leads to statistically significant inhibition of intestinal GST activity. Flubendazole treatment leads to slight but significant inhibition (decrease to 69%) of 7-ethoxyresorufin activity in hepatic microsomes.
参考文献
参考文献
  • 1. Hou ZJ, et al. Oncotarget. 2015 Jan 21;6(8):6326-40.

研究领域
研究领域
CancerCell DeathAutophagyAPG gene products
CancerCell DeathAutophagySignal Transduction
CancerInvasion/microenvironmentECMExtracellular matrixOther
CancerSignal transductionAutophagy
CardiovascularHeartAutophagyAPG gene products
Proteolysis / UbiquitinProteolytic enzymesOther proteases
MetabolismPathways and ProcessesMetabolism processesAutophagy and mitophagy
MetabolismPathways and ProcessesMetabolism processesAutophagy and mitophagyAPG gene products
NeuroscienceProcesses
Drug DiscoverySmall Molecule DrugLead Compound Discovery
Flubendazole  31430-15-6温馨提示:本产品仅作科研实验使用,不支持临床等研究

产品咨询

留言框

  • 产品:

  • 您的单位:

  • 您的姓名:

  • 联系电话:

  • 常用邮箱:

  • 省份:

  • 详细地址:

  • 补充说明:

  • 验证码:

    请输入计算结果(填写阿拉伯数字),如:三加四=7
爱必信(上海)生物科技有限公司
地址:上海市浦东新区新浩路58号申江科创园18栋
邮箱:lanwu@univ-bio.com
传真:
关注我们
欢迎您关注我们的微信公众号了解更多信息:
欢迎您关注我们的微信公众号
了解更多信息